Redox signaling in hypertension

Cardiovascular Research

Volumn 71, Issue 2, 2006, Pages 247-258

  Paravicini, Tamara M ^a   Touyz, Rhian M ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Angiotensin II; Blood pressure; Inflammation; Kinases; Signal transduction; Superoxide; Vascular remodeling; Vascular smooth muscle cells

Indexed keywords

CELL CYCLE PROTEIN; HYDROGEN PEROXIDE; ION CHANNEL; METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PEROXYNITRITE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

BLOOD PRESSURE; BLOOD VESSEL INJURY; CELL CYCLE; DISEASE ASSOCIATION; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; EXTRACELLULAR MATRIX; GENE EXPRESSION; HEMODYNAMICS; HUMAN; HYPERTENSION; INFLAMMATION; MECHANOTRANSDUCTION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

ANIMALS; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION; MECHANOTRANSDUCTION, CELLULAR; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NADPH OXIDASE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN TYROSINE PHOSPHATASES; PROTEIN-TYROSINE-PHOSPHATASE; REACTIVE OXYGEN SPECIES;

EID: 33745193908     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.05.001     Document Type: Review

References (114)

1. Schiffrin E.L., and Touyz R.M. From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension. Am J Physiol Heart Circ Physiol 287 (2004) H435-H446
2. Mulvany M.J. Small artery remodeling in hypertension. Curr Hypertens Rep 4 (2002) 49-55
3. Intengan H.D., and Schiffrin E.L. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 38 (2001) 581-587
4. Griendling K.K., Sorescu D., Lassegue B., and Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 20 (2000) 2175-2183
5. Redon J., Oliva M.R., Tormos C., Giner V., Chaves J., Iradi A., et al. Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 41 (2003) 1096-1101
6. Fortuno A., Olivan S., Beloqui O., San Jose G., Moreno M.U., Diez J., et al. Association of increased phagocytic NAD(P)H oxidase-dependent superoxide production with diminished nitric oxide generation in essential hypertension. J Hypertens 22 (2004) 2169-2175
7. Higashi Y., Sasaki S., Nakagawa K., Matsuura H., Oshima T., and Chayama K. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med 346 (2002) 1954-1962
8. Laursen J.B., Rajagopalan S., Galis Z., Tarpey M., Freeman B.A., and Harrison D.G. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 95 (1997) 588-593
9. Rajagopalan S., Kurz S., Munzel T., Tarpey M., Freeman B.A., Griendling K.K., et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NAD(P)H oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97 (1996) 1916-1923
10. Beswick R.A., Zhang H., Marable D., Catravas J.D., Hill W.D., and Webb R.C. Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension 37 (2001) 781-786
11. Heitzer T., Wenzel U., Hink U., Krollner D., Skatchkov M., Stahl R.A., et al. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. Kidney Int 55 (1999) 252-260
12. Jung O., Schreiber J.G., Geiger H., Pedrazzini T., Busse R., and Brandes R.P. gp91phox-containing NAD(P)H oxidase mediates endothelial dysfunction in renovascular hypertension. Circulation 109 (2004) 1795-1801
13. Cai H., and Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87 (2000) 840-844
14. Paravicini T.M., Chrissobolis S., Drummond G.R., and Sobey C.G. Increased NAD(P)H-oxidase activity and Nox4 expression during chronic hypertension is associated with enhanced cerebral vasodilatation to NAD(P)H in vivo. Stroke 35 (2004) 584-589
15. 2 generation play a key role in flow-mediated dilation in human coronary resistance arteries. Circ Res 93 (2003) 573-580
16. Matoba T., Shimokawa H., Nakashima M., Hirakawa Y., Mukai Y., Hirano K., et al. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest 106 (2000) 1521-1530
17. Suzuki H., DeLano F.A., Parks D.A., Jamshidi N., Granger D.N., Ishii H., et al. Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc Natl Acad Sci U S A 95 (1998) 4754-4759
18. Mervaala E.M., Cheng Z.J., Tikkanen I., Lapatto R., Nurminen K., Vapaatalo H., et al. Endothelial dysfunction and xanthine oxidoreductase activity in rats with human renin and angiotensinogen genes. Hypertension 37 (2001) 414-418
19. Laakso J., Mervaala E., Himberg J.J., Teravainen T.L., Karppanen H., Vapaatalo H., et al. Increased kidney xanthine oxidoreductase activity in salt-induced experimental hypertension. Hypertension 32 (1998) 902-906
20. Laakso J.T., Teravainen T.L., Martelin E., Vaskonen T., and Lapatto R. Renal xanthine oxidoreductase activity during development of hypertension in spontaneously hypertensive rats. J Hypertens 22 (2004) 1333-1340
21. Andrew P.J., and Mayer B. Enzymatic function of nitric oxide synthases. Cardiovasc Res 43 (1999) 521-531
22. Vasquez-Vivar J., Kalyanaraman B., Martasek P., Hogg N., Masters B.S., Karoui H., et al. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci U S A 95 (1998) 9220-9225
23. Landmesser U., Dikalov S., Price S.R., McCann L., Fukai T., Holland S.M., et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111 (2003) 1201-1209
24. Laursen J.B., Somers M., Kurz S., McCann L., Warnholtz A., Freeman B.A., et al. Endothelial regulation of vasomotion in ApoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 103 (2001) 1282-1288
25. Hong H.J., Hsiao G., Cheng T.H., and Yen M.H. Supplemention with tetrahydrobiopterin suppresses the development of hypertension in spontaneously hypertensive rats. Hypertension 38 (2001) 1044-1048
26. Bayraktutan U., Blayney L., and Shah A.M. Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells. Arterioscler Thromb Vasc Biol 20 (2000) 1903-1911
27. Li J.M., and Shah A.M. Intracellular localization and preassembly of the NAD(P)H oxidase complex in cultured endothelial cells. J Biol Chem 277 (2002) 19952-19960
28. Lassegue B., and Clempus R.E. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285 (2003) R277-R297
29. Seshiah P.N., Weber D.S., Rocic P., Valppu L., Taniyama Y., and Griendling K.K. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 91 (2002) 406-413
30. Fukui T., Ishizaka N., Rajagopalan S., Laursen J.B., Capers Q.T., Taylor W.R., et al. p22phox mRNA expression and NAD(P)H oxidase activity are increased in aortas from hypertensive rats. Circ Res 80 (1997) 45-51
31. Rey F.E., Cifuentes M.E., Kiarash A., Quinn M.T., and Pagano P.J. Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice. Circ Res 89 (2001) 408-414
32. Landmesser U., Cai H., Dikalov S., McCann L., Hwang J., Jo H., et al. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin. Hypertension 40 (2002) 511-515
33. - production, vascular tone, and mitogen-activated protein kinase activation. Circulation 109 (2004) 1307-1313
34. Matsuno K., Yamada H., Iwata K., Jin D., Katsuyama M., Matsuki M., et al. Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice. Circulation 112 (2005) 2677-2685
35. Dikalova A., Clempus R., Lassegue B., Cheng G., McCoy J., Dikalov S., et al. Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation 112 (2005) 2668-2676
36. 2. Hypertension 46 (2005) 732-737
37. Zhou M.S., Adam A.G., Jaimes E.A., and Raij L. In salt-sensitive hypertension, increased superoxide production is linked to functional upregulation of angiotensin. Hypertension 42 (2003) 945-951
38. Zhou M.S., Hernandez Schulman I., Pagano P.J., Jaimes E.A., and Raij L. Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure. Hypertension 47 (2006) 81-86
39. Zalba G., Beaumont F.J., San Jose G., Fortuno A., Fortuno M.A., Etayo J.C., et al. Vascular NADH/NAD(P)H oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 35 (2000) 1055-1061
40. Somers M.J., Mavromatis K., Galis Z.S., and Harrison D.G. Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt. Circulation 101 (2000) 1722-1728
41. Beswick R.A., Dorrance A.M., Leite R., and Webb R.C. NADH/NAD(P)H oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension 38 (2001) 1107-1111
42. Callera G.E., Touyz R.M., Teixeira S.A., Muscara M.N., Carvalho M.H., Fortes Z.B., et al. ETA receptor blockade decreases vascular superoxide generation in DOCA-salt hypertension. Hypertension 42 (2003) 811-817
43. Li L., Fink G.D., Watts S.W., Northcott C.A., Galligan J.J., Pagano P.J., et al. Endothelin-1 increases vascular superoxide via endothelin(A)-NAD(P)H oxidase pathway in low-renin hypertension. Circulation 107 (2003) 1053-1058
44. Elmarakby A.A., Loomis E.D., Pollock J.S., and Pollock D.M. NAD(P)H oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1. Hypertension 45 (2005) 283-287
45. Amiri F., Virdis A., Neves M.F., Iglarz M., Seidah N.G., Touyz R.M., et al. Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction. Circulation 110 (2004) 2233-2240
46. Zimmerman M.C., Lazartigues E., Lang J.A., Sinnayah P., Ahmad I.M., Spitz D.R., et al. Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res 91 (2002) 1038-1045
47. Zimmerman M.C., Dunlay R.P., Lazartigues E., Zhang Y., Sharma R.V., Engelhardt J.F., et al. Requirement for Rac1-dependent NAD(P)H oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain. Circ Res 95 (2004) 532-539
48. Zimmerman M.C., Lazartigues E., Sharma R.V., and Davisson R.L. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res 95 (2004) 210-216
49. Kishi T., Hirooka Y., Kimura Y., Ito K., Shimokawa H., and Takeshita A. Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation 109 (2004) 2357-2362
50. Lehoux S., and Tedgui A. Signal transduction of mechanical stresses in the vascular wall. Hypertension 32 (1998) 338-345
51. Kojda G., and Hambrecht R. Molecular mechanisms of vascular adaptations to exercise. Physical activity as an effective antioxidant therapy. Cardiovasc Res 67 (2005) 187-197
52. Harrison D.G., Widder J., Grumbach I., Chen W., Weber M., and Searles C. Endothelial mechanotransduction, nitric oxide and vascular inflammation. J Intern Med 259 (2006) 351-363
53. Corson M.A., James N.L., and Latta S.E. Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress. Circ Res 79 (1996) 984-991
54. Boo Y.C., and Jo H. Flow-dependent regulation of endothelial nitric oxide synthase: role of protein kinases. Am J Physiol Cell Physiol 285 (2003) C499-C508
55. Cai H., McNally J.S., Weber M., and Harrison D.G. Oscillatory shear stress upregulation of endothelial nitric oxide synthase requires intracellular hydrogen peroxide and CaMKII. J Mol Cell Cardiol 37 1 (2004) 121-125
56. Laurindo F.R., Pedro Mde A., Barbeiro H.V., Pileggi F., Carvalho M.H., Augusto O., et al. Vascular free radical release. Ex vivo and in vivo evidence for a flow-dependent endothelial mechanism. Circ Res 74 (1994) 700-709
57. De Keulenaer G.W., Chappell D.C., Ishizaka N., Nerem R.M., Alexander R.W., and Griendling K.K. Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: role of a superoxide-producing NADH oxidase. Circ Res 82 (1998) 1094-1101
58. Ali M.H., Pearlstein D.P., Mathieu C.E., and Schumacker P.T. Mitochondrial requirement for endothelial responses to cyclic strain: implications for mechanotransduction. Am J Physiol 287 (2004) L486-L496
59. Hilenski L.L., Clempus R.E., Quinn M.T., Lambeth J.D., and Griendling K.K. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 24 (2004) 677-683
60. Touyz R.M., Yao G., Quinn M.T., Pagano P.J., and Schiffrin E.L. p47phox associates with the cytoskeleton through cortactin in human vascular smooth muscle cells: role in NAD(P)H oxidase regulation by angiotensin II. Arterioscler Thromb Vasc Biol 25 (2005) 512-518
61. Hwang J., Ing M.H., Salazar A., Lassegue B., Griendling K., Navab M., et al. Pulsatile versus oscillatory shear stress regulates NAD(P)H oxidase subunit expression: implication for native LDL oxidation. Circ Res 93 (2003) 1225-1232
62. Go Y.-M., Patel R.P., Maland M.C., Park H., Beckman J.S., Darley-Usmar V.M., et al. Evidence for peroxynitrite as a signaling molecule in flow-dependent activation of c-Jun NH2-terminal kinase. Am J Physiol Heart Circ Physiol 277 (1999) H1647-H1653
63. Castier Y., Brandes R.P., Leseche G., Tedgui A., and Lehoux S. p47phox-dependent NAD(P)H oxidase regulates flow-induced vascular remodeling. Circ Res 97 (2005) 533-540
64. Liu Y., Bubolz A.H., Shi Y., Newman P.J., Newman D.K., and Gutterman D.D. Peroxynitrite reduces the endothelium-derived hyperpolarizing factor component of coronary flow-mediated dilation in PECAM 1-knockout mice. Am J Physiol 290 (2005) 57-65
65. Beckman J.S., and Koppenol W.H. Nitric oxide, superoxide and peroxynitrite: the good, the bad and the ugly. Am J Physiol 271 (1996) C1424-C1437
66. Inoue N., Ramasamy S., and Fukai T. Shear stress modulates expression of Cu/Zn superoxide dismutase in human aortic endothelial cells. Circ Res 79 (1996) 32-37
67. Mueller C.F., Widder J.D., and McNally J.S. The role of the multidrug resistance protein-1 in modulation of endothelial cell oxidative stress. Circ Res 97 (2005) 637-644
68. Miura H., Bosnjak J.J., Ning G., Saito T., Miura M., and Gutterman D.D. Role for hydrogen peroxide in flow-induced dilation of human coronary arterioles. Circ Res 92 (2003) e31-e40
69. Paravicini T.M., Miller A.A., Drummond G.R., and Sobey C.G. Flow-induced cerebral vasodilatation in vivo involves activation of phosphatidylinositol-3 kinase, NADPH-oxidase, and nitric oxide synthase. J Cereb Blood Flow Metab 26 6 (2006) 836-845
70. Oeckler R.A., Kaminski P.M., and Wolin M.S. Stretch enhances contraction of bovine coronary arteries via an NAD(P)H oxidase-mediated activation of the extracellular signal-regulated kinase mitogen-activated protein kinase cascade. Circ Res 92 (2003) 23-31
71. Ungvari Z., Csiszar A., Huang A., Kaminski P.M., Wolin M.S., and Koller A. High pressure induces superoxide production in isolated arteries via protein kinase C-dependent activation of NAD(P)H oxidase. Circulation 108 (2003) 1253-1258
72. Pearson G., Robinson F., Beers Gibson T., Xu B.E., Karandikar M., Berman K., et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22 (2001) 153-183
73. Ushio-Fukai M., Alexander R.W., Akers M., and Griendling K.K. p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J Biol Chem 273 (1998) 15022-15029
74. Eguchi S., Dempsey P.J., Frank G.D., Motley E.D., and Inagami T. Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK. J Biol Chem 276 (2001) 7957-7962
75. 2 for platelet-derived growth factor signal transduction. Science 270 (1995) 296-299
76. - in vascular smooth muscle cells. Circ Res 77 (1995) 29-36
77. Viedt C., Soto U., Krieger-Brauer H.I., Fei J., Elsing C., Kubler W., et al. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species. Arterioscler Thromb Vasc Biol 20 (2000) 940-948
78. Meloche S., Landry J., Huot J., Houle F., Marceau F., and Giasson E. p38 MAP kinase pathway regulates angiotensin II-induced contraction of rat vascular smooth muscle. Am J Physiol Heart Circ Physiol 279 (2000) H741-H751
79. Torrecillas G., Boyano-Adanez M.C., Medina J., Parra T., Griera M., Lopez-Ongil S., et al. The role of hydrogen peroxide in the contractile response to angiotensin II. Mol Pharmacol 59 (2001) 104-112
80. Touyz R.M., He G., El Mabrouk M., and Schiffrin E.L. p38 Map kinase regulates vascular smooth muscle cell collagen synthesis by angiotensin II in SHR but not in WKY. Hypertension 37 (2001) 574-580
81. Lassegue B., Sorescu D., Szocs K., Yin Q., Akers M., Zhang Y., et al. Novel gp91(phox) homologues in vascular smooth muscle cells : Nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 88 (2001) 888-894
82. Lehoux S., Esposito B., Merval R., Loufrani L., and Tedgui A. Pulsatile stretch-induced extracellular signal-regulated kinase 1/2 activation in organ culture of rabbit aorta involves reactive oxygen species. Arterioscler Thromb Vasc Biol 20 (2000) 2366-2372
83. Saito Y., and Berk B.C. Transactivation: a novel signaling pathway from angiotensin II to tyrosine kinase receptors. J Mol Cell Cardiol 33 (2001) 3-7
84. Ushio-Fukai M., Griendling K.K., Becker P.L., Hilenski L., Halleran S., and Alexander R.W. Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 21 (2001) 489-495
85. Chen K., Vita J.A., Berk B.C., and Keaney Jr. J.F. c-Jun N-terminal kinase activation by hydrogen peroxide in endothelial cells involves SRC-dependent epidermal growth factor receptor transactivation. J Biol Chem 276 (2001) 16045-16050
86. Prenzel N., Zwick E., Daub H., Leserer M., Abraham R., Wallasch C., et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402 (1999) 884-888
87. Frank G.D., Mifune M., Inagami T., Ohba M., Sasaki T., Higashiyama S., et al. Distinct mechanisms of receptor and nonreceptor tyrosine kinase activation by reactive oxygen species in vascular smooth muscle cells: role of metalloprotease and protein kinase C-delta. Mol Cell Biol 23 (2003) 1581-1589
88. Mifune M., Ohtsu H., Suzuki H., Nakashima H., Brailoiu E., Dun N.J., et al. G protein coupling and second messenger generation are indispensable for metalloprotease-dependent, heparin-binding epidermal growth factor shedding through angiotensin II type-1 receptor. J Biol Chem 280 (2005) 26592-26599
89. Touyz R.M., Wu X.H., He G., Salomon S., and Schiffrin E.L. Increased angiotensin II-mediated Src signaling via epidermal growth factor receptor transactivation is associated with decreased C-terminal Src kinase activity in vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension 39 (2002) 479-485
90. Touyz R.M., Yao G., and Schiffrin E.L. c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 23 (2003) 981-987
91. Cheng J.J., Chao Y.J., and Wang D.L. Cyclic strain activates redox-sensitive proline-rich tyrosine kinase 2 (PYK2) in endothelial cells. J Biol Chem 277 (2002) 48152-48157
92. Matrougui K., Eskildsen-Helmond Y.E., Fiebeler A., Henrion D., Levy B.I., Tedgui A., et al. Angiotensin II stimulates extracellular signal-regulated kinase activity in intact pressurized rat mesenteric resistance arteries. Hypertension 36 (2000) 617-621
93. Wesselman J.P., Dobrian A.D., Schriver S.D., and Prewitt R.L. Src tyrosine kinases and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases mediate pressure-induced c-fos expression in cannulated rat mesenteric small arteries. Hypertension 37 (2001) 955-960
94. Stoker A.W. Protein tyrosine phosphatases and signalling. J Endocrinol 185 1 (2005) 19-33
95. Tonks N.K. Redox redux: revisiting PTPs and the control of cell signaling. Cell 121 5 (2005) 667-670
96. Murphy T.V., Spurrell B.E., and Hill M.A. Tyrosine phosphorylation following alterations in arteriolar intraluminal pressure and wall tension. Am J Physiol Heart Circ Physiol 281 3 (2001) H1047-H1056
97. Lee S.R., Kwon K.S., Kim S.R., and Rhee S.G. Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J Biol Chem 273 25 (1998) 15366-15372
98. Lehoux S., Lemarie C.A., Esposito B., Lijnen H.R., and Tedgui A. Pressure-induced matrix metalloproteinase-9 contributes to early hypertensive remodeling. Circulation 109 (2004) 1041-1047
99. Rajagopalan S., Meng X.P., Ramasamy S., Harrison D.G., and Galis Z.S. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 98 (1996) 2572-2579
100. Grote K., Flach I., Luchtefeld M., Akin E., Holland S.M., Drexler H., et al. Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species. Circ Res 92 (2003) e80-e86
101. Luchtefeld M., Grote K., Grothusen C., Bley S., Bandlow N., Selle T., et al. Angiotensin II induces MMP-2 in a p47phox-dependent manner. Biochem Biophys Res Commun 328 (2005) 183-188
102. Lucchesi P.A., Sabri A., Belmadani S., and Matrougui K. Involvement of metalloproteinases 2/9 in epidermal growth factor receptor transactivation in pressure-induced myogenic tone in mouse mesenteric resistance arteries. Circulation 110 (2004) 3587-3593
103. Davis M.J., and Hill M.A. Signaling mechanisms underlying the vascular myogenic response. Physiol Rev 79 (1999) 387-423
104. Schieffer B., Luchtefeld M., Braun S., Hilfiker A., Hilfiker-Kleiner D., and Drexler H. Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction [in process citation]. Circ Res 87 (2000) 1195-1201
105. Simon A.R., Rai U., Fanburg B.L., and Cochran B.H. Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol 275 (1998) C1640-C1652
106. Cheng J.J., Wung B.S., Chao Y.J., and Wang D.L. Cyclic strain-induced reactive oxygen species involved in ICAM-1 gene induction in endothelial cells. Hypertension 31 (1998) 125-130
107. Pueyo M.E., Gonzalez W., Nicoletti A., Savoie F., Arnal J.F., and Michel J.B. Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress. Arterioscler Thromb Vasc Biol 20 (2000) 645-651
108. Tummala P.E., Chen X.L., Sundell C.L., Laursen J.B., Hammes C.P., Alexander R.W., et al. Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: a potential link between the renin-angiotensin system and atherosclerosis. Circulation 100 (1999) 1223-1229
109. De Ciuceis C., Amiri F., Brassard P., Endemann D.H., Touyz R.M., and Schiffrin E.L. Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury. Arterioscler Thromb Vasc Biol 25 (2005) 2106-2113
110. Liu J., Yang F., Yang X.P., Jankowski M., and Pagano P.J. NAD(P)H oxidase mediates angiotensin II-induced vascular macrophage infiltration and medial hypertrophy. Arterioscler Thromb Vasc Biol 23 (2003) 776-782
111. Cakir Y., and Ballinger S.W. Reactive species-mediated regulation of cell signaling and the cell cycle: the role of MAPK. Antioxid Redox Signal 7 (2005) 726-740
112. Iida Y., and Katusic Z.S. Mechanisms of cerebral arterial relaxations to hydrogen peroxide. Stroke 31 (2000) 2224-2230
113. + channels. Stroke 28 (1997) 2290-2294 [discussion 2295]
114. Barlow R.S., and White R.E. Hydrogen peroxide relaxes porcine coronary arteries by stimulating BKCa channel activity. Am J Physiol 275 (1998) H1283-H1289